Differential effects of MK801 and lorazepam on heart rate variability in adolescent rhesus monkeys (Macaca Mulatta)

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 5, 2005, Pages 383-388

  Bennett, Allyson J ^a   DePetrillo, Paolo B ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cardiac; Heart rate variability; Lorazepam; MK801; Monkey; NMDA

Indexed keywords

DIZOCILPINE; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG INFUSION; DYNAMICS; FOURIER TRANSFORMATION; HEART RATE VARIABILITY; HEART RHYTHM; MACACA; MALE; NONHUMAN; NONLINEAR SYSTEM; PRIMATE; PRIORITY JOURNAL; SEDATION; SIGNAL TRANSDUCTION; TIME;

ANIMALS; DIZOCILPINE MALEATE; ELECTROCARDIOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; FOURIER ANALYSIS; HEART RATE; HYPNOTICS AND SEDATIVES; LORAZEPAM; MACACA MULATTA; MALE;

EID: 18244389461     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000156820.12339.db     Document Type: Article

References (44)

1. Wright M. Pharmacologic effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc. 1982;180:1462-1471.
2. Bergman SA. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999;46:10-20.
3. Cohen BJ, Bree MM. Chemical and physical restraint of nonhuman primates. J Med Primatol. 1978;7:193-201.
4. Tobias JD. Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use. Paediatr Drugs. 1999;1:109-126.
5. Green SM, Clem KJ, Rothrock SG. Ketamine safety profile in the developing world: survey of practitioners. Acad Emerg Med. 1996;3:598-604.
6. Bonanno FG. Ketamine in war/tropical surgery (a final tribute to the racemic mixture). Injury. 2002;33:323-327.
7. SAMHSA/Office of Applied Studies. The DAWN Report: Club Drugs. SAMHSA/Office of Applied Studies; 2000:1-10.
8. Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998;274:H747-H751.
9. D'Amico M, Di Filippo C, Rossi F. Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. Eur J Pharmacol. 1999;366:167-174.
10. Aya AG, Robert E, Bruelle P, et al. Effects of ketamine on ventricular conduction, refractoriness, and wavelength: potential antiarrhythmic effects: a high-resolution epicardial mapping in rabbit hearts. Anesthesiology. 1997;87:1417-1427.
11. Baczko I, Lepran I, Papp JG. Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats. J Cardiovasc Pharmacol. 1997;29:196-201.
12. Gonder JC, Gard EA, Lott NE. Electrocardiograms of nine species of nonhuman primates sedated with ketamine. Am J Vet Res. 1980;41:972-975.
13. Berrino L, Cuparencu B, de Novellis V, et al. Central arrhythmogenic effects of N-methyl-D-aspartate (NMDA) in anesthetized rats: influence of the denervation of the carotid-sinus baroreceptors on the susceptibility to arrhythmias. Res Commun Chem Pathol Pharmacol. 1992;78:141-149.
14. Weiner AL, Vieira L, McKay CA, et al. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med. 2000;18:447-451.
15. Peters JA, Malone HM, Lambert JJ. Ketamine potentiates 5-HT3 receptor-mediated currents in rabbit nodose ganglion neurones. Br J Pharmacol. 1991;103:1623-1625.
16. Nishimura M, Sato K, Okada T, et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology. 1998;88:768-774.
17. DePetrillo PB, Bennett AJ, Speers d'A, et al. Ondansetron modulates pharmacodynamic effects of ketamine on electrocardiographic signals in rhesus monkeys. Eur J Pharmacol. 2000;391:113-119.
18. DePetrillo PB, Ruttiman U, Speers D'A. Determining the Hurst component of fractal time series and its application to electrocardiographic analysis. Comput Biol Med. 1999;29:393-406.
19. Delaney JP, Brodie DA. Effects of short-term psychological stress on the time and frequency domains of heart-rate variability. Percept Mot Skills. 2000;91:515-524.
20. Dishman RX, Nakamura Y, Garcia ME, et al. Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol. 2000;37:121-133.
21. Sloan RP, Shapiro PA, Bagiella E, et al. Effect of mental stress throughout the day on cardiac and autonomic control. Biol Psychol. 1994;37:88-99.
22. De Petrillo PB, White KV, Liu M, et al. Effects of alcohol use and gender on the dynamics of EKG time series data. Alcohol Clin Exp Res. 1999;23:745-750.
23. Yamamoto Y, Hughson RL. Coarse-graining spectral analysis: new method for studying heart rate variability. J Appl Physiol. 1991;71:1143-1150.
24. Yamamoto Y, Hughson RL. Extracting the fractal components from time series. Physica D. 1993;68:250-264.
25. Nakamura Y, Yamamoto Y, Muraoka I. Autonomic control of heart rate during physical exercise and fractal dimension of heart rate variability. J Appl Physiol. 1993;74:875-881.
26. Fortrat JO, Formet C, Frutoso J, et al. Even slight movements disturb analysis of cardiovascular dynamics. Am J Physiol Heart Circ Physiol. 1999;277:H261-H267.
27. Fukusaki C, Kawakubo K, Yamamoto Y. Asessment of the primary effect of aging on heart rate variability in humans. Clin Auton Res. 2000;10:123-130.
28. Yamamoto Y, LaManca JJ, Natelson BH. A measure of heart rate variability is sensitive to orthostatic challenge in women with chronic fatigue syndrome. Exp Biol Med. 2003;228:167-174.
29. Yamamoto Y, Nakamura Y, Sato H, et al. On the fractal nature of heart rate variability in humans: effects of vagal blockade. Am J Physiol. 1995;269: R830-R837.
30. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol. 1999;276:H215-H223.
31. Yamamoto Y, Hughson RL, Peterson JC. Autonomic control of heart rate during exercise studied by heart rate variability spectral analysis. J Appl Physiol. 1991;71:1136-1142.
32. Gonzalez JJ, Cordero JJ, Feria M, et al. Detection and sources of nonlinearity in the variability of cardiac R-R intervals and blood pressure in rats. Am J Physiol Heart Circ Physiol. 2000;279:H3040-H3046.
33. Goldberger JJ, Ahmed MW, Parker MA, et al. Dissociation of heart rate variability from parasympathetic tone. Am J Physiol. 1994;266:H2152-H2157.
34. Goldberger JJ, Kim YH, Ahmed MW, et al. Effect of graded increases in parasympathetic tone on heart rate variability. J Cardiovasc Electrophysiol. 1996;7:594-602.
35. Bloomfield DM, Magnano A, Bigger JT Jr I, et al. Comparison of spontaneous vs. metronome-guided breathing on assessment of vagal modulation using RR variability. Am J Physiol Heart Circ Physiol. 2001;280:H1145-H1150.
36. Vogel LR, Muskin PR, Collins ED, et al. Lorazepam reduces cardiac vagal modulation in normal subjects. J Clin Psychopharmacol. 1996;16:449-453.
37. Schwartz PJ, LaRovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and Clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;85(1 Suppl):177-191.
38. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med. 1999;50:249-261.
39. Hageman GR, Simor T. Attenuation of the cardiac effects of cocaine by dizocilpine. Am J Physiol. 1993;264:H1890-1895.
40. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol. 1996;28:1183-1189.
41. Makikallio TH, Hoiber S, Kober L, et al. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. Am J Cardiol. 1999;83:836-839.
42. Makikallio TH, Huikuri HV, Hintze U, et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol. 2001;87:178-182.
43. Malik M, Camm AJ, Janse MJ, et al. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol. 2000;35:1263-1275.
44. Villareal RP, Liu BC, Massumi A. Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep. 2002;4:120-127.